OpenVSafe by OpenVAERS
Search V-safe

2WF-10329-27058

2 vaccinations 6 coded responses 14 check-ins 6 free-text entries 0 call cases
Sex
Male
Age at first dose
56-60
ZIP prefix
303 / GA
Registered
2021-01-30
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-31
    Dose 1 — Moderna
  2. 2021-01-29
    Dose 2 — Moderna
  3. 2021-01-30
    Registered in v-safe
  4. 2021-01-30
    Survey response — days 1–6 daily, dose 2
    MedDRA: Ageusia, Confusional state, Hypogeusia, Hyposmia, Parosmia — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Slight confusion, some decreased taste and smell (NOT Complete)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-01-31
    Survey response — days 1–6 daily, dose 2
    MedDRA: Confusional state — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Free text: Confusion is better and sense of smell returned. This is odd and I haven't heard it reported before so hope it helps in understanding pathophysiology of this in Covid19.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-02-02
    Survey response — days 1–6 daily, dose 2
    MedDRA: Anosmia — Feeling: Fair · Fatigue or tiredness, Nausea, Diarrhea · Be unable to work, Be unable to do your normal daily activities
    Free text: Sense of smell returned completely.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-02-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Fatigue or tiredness · Be unable to work
    Adult check-in
  8. 2021-02-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Fatigue or tiredness · Be unable to work
    Adult check-in
  9. 2021-02-05
    Survey response — day 7, dose 2
    MedDRA: Gingival discomfort, Gingival pain — Feeling: Fair · Fatigue or tiredness · Be unable to work
    Free text: Wanted to note that in first few days after shot I had gingival pain and irritation I couldn't otherwise explain. Has now resolved.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-02-12
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-02-19
    Health check-in — day 21, dose 2
    Feeling: Fair
    Adult check-in
  12. 2021-02-26
    Health check-in — day 28, dose 2
    Feeling: Fair
    Adult check-in
  13. 2021-03-05
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-03-12
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-05-01
    Survey response — 3 months, dose 2
    MedDRA: Dry eye — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities
    Free text: Severe dry eyes right worse than left. Mildly improved with Restaysis and punctal plugs.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-07-30
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  17. 2022-01-29
    Survey response — 12 months, dose 2
    MedDRA: Electromyogram abnormal, Peripheral sensorimotor neuropathy, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Sensorimotor Peripheral pyneuropathy....diagnosed by (b)(6). Started 2_3 months ago. Also chronic dry eye which is resistant to treatment...started in April.
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12020-12-31Moderna
22021-01-29Moderna

Free text

Release 3 — days 1–6 daily, dose 2

2021-01-30

Systemic reaction (other): Slight confusion, some decreased taste and smell (NOT Complete)

2021-01-31

Systemic reaction (other): Confusion is better and sense of smell returned. This is odd and I haven't heard it reported before so hope it helps in understanding pathophysiology of this in Covid19.

2021-02-02

Systemic reaction (other): Sense of smell returned completely.

Release 3 — day 7, dose 2

2021-02-05

Systemic reaction (other): Wanted to note that in first few days after shot I had gingival pain and irritation I couldn't otherwise explain. Has now resolved.

Release 8 — 3 months, dose 2

2021-05-01

Symptoms: Severe dry eyes right worse than left. Mildly improved with Restaysis and punctal plugs.

Release 11 — 12 months, dose 2

2022-01-29

Symptoms: Sensorimotor Peripheral pyneuropathy....diagnosed by (b)(6). Started 2_3 months ago. Also chronic dry eye which is resistant to treatment...started in April.
redacted (b)(6)

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDDry eye ✓ ✓ ✓
SDElectromyogram abnormal · · ✓
SDPeripheral sensorimotor neuropathy · · ✓
SDPre-existing disease · · ✓
SROAgeusia ✓ ✓ ○
SROAnosmia ✓ ✓ ✓
SROConfusional state ✓ ✓ ✓
SROGingival discomfort ✓ ✓ ✓
SROGingival pain ✓ ✓ ✓
SROHypogeusia · · ✓
SROHyposmia · · ✓
SROParosmia ✓ ✓ ○

✓ active code · ○ coded but marked inactive · blank = not in that release